Get in Touch with Our Team
IBH’s Data Analysis Services (National Addictions Vigilance Intervention and Prevention Program: NAVIPPRO) work to better understand prescription opioid and stimulant use/abuse and the effectiveness of abuse-deterrent formulations (ADF).
Real-time monitoring of prescription drug use and abuse with sentinel, high-risk populations ensure state-of-the-art pharmacovigilance and rapid detection of unanticipated outcomes
We work closely with clients to tailor exploratory or hypothesis-driven epidemiological studies, which include:
Customized solutions ensure the most valuable assessments for your product. All Risk Evaluation and Mitigation Strategies (REMS) must include an approach to assessing the effectiveness of their safety measures.
We work with our clients to develop strategies to conduct the most appropriate assessments for both patients and providers. These may include knowledge assessments to evaluate the effectiveness of the REMS activities in informing patients and providers about safe use or conducting drug utilization studies to evaluate appropriate prescribing.
We work with clients to identify the best strategy for data dissemination of key findings to support scientific, regulatory, and business objectives. In partnership with our clients, we design and implement studies, articulate key messages, and develop a strategic plan to reach target audiences.